Related Experiment Videos
A cell-cycle-phase-specific mutant of amoeba
Abstract:
The treatment of Amoeba indica with ethylmethanesulphonate (EMS) at early S, late S and late G2 phases of the cell cycle leads to the production of mini amoeba cells in the G2 period. Among them, only a few of the mini cells that originated from EMS treatment at early S phase have been found to be viable and to give rise to stable clones. These mini amoebae show stable and altered characteristic features in cell size, structure, membrane properties, cell-cycle timing and the patterns of macromolecular syntheses as compared to the parental cells. It is suggested that the mini amoeba cell is a size mutant that has a cell-cycle-phase-specific origin. The finding is discussed in relation to preferential mutagenic action involving the functional state of DNA leading to the production of viable mutant amoebae.
Insights
Ethylmethanesulphonate (EMS) treatment of Amoeba indica can produce viable mini amoeba cells, particularly when applied during the early S phase. These mini amoebae exhibit stable, altered characteristics, suggesting a cell-cycle-specific origin for this size mutant.
Area of Science:
- Cell Biology
- Mutagenesis
- Developmental Biology
Background:
- Ethylmethanesulphonate (EMS) is a chemical mutagen used to induce genetic alterations.
- The cell cycle comprises distinct phases (G1, S, G2, M) with varying sensitivities to mutagens.
- Amoeba are single-celled organisms widely used in biological research.
Purpose of the Study:
- To investigate the effect of EMS treatment on Amoeba indica at different cell cycle phases.
- To characterize the resulting mini amoeba cells and assess their viability and stability.
- To understand the relationship between DNA's functional state and mutagenesis.
Main Methods:
- Treatment of Amoeba indica with ethylmethanesulphonate (EMS) at specific cell cycle phases (early S, late S, late G2).
- Observation and characterization of mini amoeba cells produced post-treatment.
- Analysis of cell size, structure, membrane properties, cell-cycle timing, and macromolecular synthesis patterns.
Main Results:
- EMS treatment induced mini amoeba formation, primarily in the G2 phase.
- Mini amoebae derived from early S phase EMS treatment showed higher viability and formed stable clones.
- These viable mini amoebae displayed stable, altered characteristics compared to parental cells.
Conclusions:
- The mini amoeba is a size mutant with a cell-cycle-phase-specific origin.
- Early S phase appears to be a critical window for generating viable, stable mutants with EMS.
- Preferential mutagenic action on functionally distinct DNA states may lead to viable mutant amoebae.